The wait is over
If you have chronic kidney disease (CKD), you’re probably thinking about how essential your kidneys are. You’ve got your future in mind and are taking steps to slow the progression toward end-stage kidney disease, which could mean dialysis or a kidney transplant. But what if there were a medicine that may help you reach your goals? Now there’s a new option to consider.
Discover the FARXIGA difference
What the FDA is saying
The Food and Drug Administration granted FARXIGA its “Breakthrough Therapy Designation” for its review in chronic kidney disease. That means it may provide substantial improvement over treatments that are currently available for the treatment of CKD.
What this may mean for you
With FARXIGA, you could keep living life by reducing the serious risks of CKD, including death due to cardiovascular disease. This is true whether or not you have type 2 diabetes.
FIRST CKD TREATMENT APPROVED IN 20 YEARS FOR PATIENTS WITH AND WITHOUT TYPE 2 DIABETES
HELPS YOU KEEP LIVINGBY REDUCING THE RISK OF CV DEATH
First approved CKD treatment in decades for patients with and without type 2 diabetes, FARXIGA is proven to help by:
progression of CKD
Reducing the risk of end-stage kidney disease, which can lead to dialysis
Keeping you living life by reducing the risk of